The endotoxin testing market size is estimated to be USD 2,345 million in 2022 and is expected to witness a CAGR of 6.5% during the forecast period 2023-2033. Increased automation of reporting, management processes, and data collecting, a rise in the usage of endotoxin testing techniques in end-use sectors including the packaging, pharmaceutical, and medical device industries, modern laboratory testing techniques, and the development of technology are factors contributing to the market growth. However, strong government laws on animal experimentation is expected to hinder the growth.

Segmentation

By Test Type

Based on test type, the market is segregated into recombinant factor c (rFC) assay, rabbit pyrogen test, monocyte activation test (MAT), limulus amebocyte lysate test (LAL), and others. In 2022, the limulus amebocyte lysate test (LAL) segment held the highest market share owing to the growing need for non-animal testing techniques and improved LAL testing accuracy and growing biologics need.

By Application

On the basis of application, the market is categorized into raw materials production, pharmaceutical manufacturing, medical device manufacturing, and packaging manufacture. In 2022, the medical device manufacturing segment held the highest market share due to the rising usage of endotoxin testing equipment and solutions and increasing endotoxin tests for injectable pharmaceuticals and implanted medical devices.

By Product Type

Based on product type, the market is bifurcated into instruments & systems, endotoxin detection kits & reagents, and consumables & accessories. In 2022, the endotoxin detection kits & reagents segment held the highest market share owing to the growing use of these kits across a range of end industries and the rising production of endotoxin detection kits and reagents by a large number of manufacturing industries.

Regional Markets

In 2022, North America region accounted for the highest revenue in the endotoxin testing market and is expected to maintain its dominance during the forecast period. This is attributed to the increasing demand for medical gadgets, rising U.S. FDA product approvals, and increasing technological developments in endotoxin testing. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the increasing use of cutting-edge tools and equipment for vaccine research and development and the significant financial expenditures in the pharmaceutical and biotechnology sectors.

Competitor Insights

Some of the key players operating in the endotoxin testing market are Biogenuix Medsystems Pvt. Ltd (India), Bio-Synthesis Inc (US), Charles River (US), Eurofins Scientific (France), GenScrip (US), Lonza (Switzerland), Merck KGaA (Germany), Nelson Laboratories LLC (US), Pace Analytical Services, LLC (US), Pacific BioLabs (US), Sartorius AG (Germany), SGS SA (Switzerland), Thermo Fisher Scientific, Inc (US), TOXIKON (US), and WuXi AppTec (China).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including test type, application, and product type from 2023 to 2033.

Report Scope:

Segmentation: Endotoxin Testing Market Report 2022 – 2033

Test Type (Revenue, USD Million), 2022 – 2033

• Recombinant Factor C (rFC) Assay
• Rabbit Pyrogen Test
• Monocyte Activation Test (MAT)
• Limulus Amebocyte Lysate Test (LAL)
• Others

Application (Revenue, USD Million), 2022 – 2033

• Raw materials production
• Pharmaceutical manufacturing
• Medical device manufacturing
• Packaging manufacture

Product Type (Revenue, USD Million), 2022 – 2033

• Instruments & Systems
• Endotoxin Detection Kits & Reagents
• Consumables & Accessories

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA